Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia
- PMID: 15126170
- DOI: 10.1016/j.ajo.2003.10.048
Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia
Abstract
Purpose: To report a case of conjunctival-corneal intraepithelial neoplasia (CCIN) in an elderly African American patient treated with topical mitomycin C and the subsequent complication of limbal stem cell deficiency.
Design: Interventional case report.
Methods: A 92-year-old African American woman was diagnosed with CCIN in the right eye. Following incisional biopsy, the patient received five 1-week courses of 0.04% mitomycin C and was followed over a period of 10 months.
Results: The CCIN regressed completely following mitomycin C therapy. Three months later, the patient developed recurrent nonhealing epithelial defects in the right cornea.
Conclusions: Conjunctival-corneal intraepithelial neoplasia may occur in the African American population. Although MMC is effective in eradicating CCIN, a limbal stem cell deficiency may complicate the treatment.
Similar articles
-
Treatment of ocular surface squamous neoplasia with Mitomycin C.Br J Ophthalmol. 2010 May;94(5):555-8. doi: 10.1136/bjo.2009.168294. Br J Ophthalmol. 2010. PMID: 20447963 Review.
-
Successful treatment of recurrent corneal intraepithelial neoplasia with topical mitomycin C.Cornea. 1997 Sep;16(5):595-7. Cornea. 1997. PMID: 9294697
-
Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.Ophthalmology. 1997 Dec;104(12):2085-93. doi: 10.1016/s0161-6420(97)30055-4. Ophthalmology. 1997. PMID: 9400769 Clinical Trial.
-
Limbal stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia.Ophthalmology. 2010 Mar;117(3):431-7. doi: 10.1016/j.ophtha.2009.07.032. Epub 2010 Jan 8. Ophthalmology. 2010. PMID: 20060167
-
Topical medical therapies for ocular surface tumors.Semin Ophthalmol. 2006 Jul-Sep;21(3):161-9. doi: 10.1080/08820530500351694. Semin Ophthalmol. 2006. PMID: 16912014 Review.
Cited by
-
Presentation, diagnosis and management of limbal stem cell deficiency.Middle East Afr J Ophthalmol. 2013 Jan-Mar;20(1):5-10. doi: 10.4103/0974-9233.106381. Middle East Afr J Ophthalmol. 2013. PMID: 23580847 Free PMC article. Review.
-
The development of scleromalacia after regional conjunctivectomy with the postoperative application of mitomycin C as an adjuvant therapy.Korean J Ophthalmol. 2013 Jun;27(3):208-10. doi: 10.3341/kjo.2013.27.3.208. Epub 2013 Apr 9. Korean J Ophthalmol. 2013. PMID: 23730115 Free PMC article.
-
Topical pharmacotherapy for ocular surface squamous neoplasia: systematic review and meta-analysis.Sci Rep. 2022 Aug 20;12(1):14221. doi: 10.1038/s41598-022-18545-6. Sci Rep. 2022. PMID: 35987957 Free PMC article.
-
Diagnosis and Medical Management of Ocular Surface Squamous Neoplasia.Expert Rev Ophthalmol. 2017;12(1):11-19. doi: 10.1080/17469899.2017.1263567. Epub 2016 Dec 5. Expert Rev Ophthalmol. 2017. PMID: 28184236 Free PMC article.
-
Recombinant Interferon Alpha-2b as Primary Treatment for Ocular Surface Squamous Neoplasia.J Curr Ophthalmol. 2021 Oct 22;33(3):260-265. doi: 10.4103/2452-2325.329089. eCollection 2021 Jul-Sep. J Curr Ophthalmol. 2021. PMID: 34765812 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical